Trulieve Cannabis TRLV
NYSE TRLV
$9.65 +0.18 (+1.90%)
At close: Aug 18, 2026 · 3:59 PM UTC

Trulieve Cannabis (TRLV) Short term Debt (2020 - 2022)

Trulieve Cannabis (TRLV) posted quarterly Short term Debt of $34.7 million for Q4 2022, up 166.31% year-over-year from $13.0 million in Q4 2021, and up 35.47% quarter-over-quarter from $25.6 million in Q3 2022.

Trulieve Cannabis (TRLV) Short term Debt (2020 - 2022) Analysis & Trends

Trulieve Cannabis' Short term Debt history runs 3 years deep, the most recent figure standing at $34.7 million for Q4 2022.

  • In Q4 2022, Short term Debt rose 166.31% year-over-year to $34.7 million; the TTM figure through Dec 2022 stood at $34.7 million (up 166.31% YoY), while the FY2022 annual figure was $34.7 million, up 166.31% from the prior year.
  • Short term Debt for Q4 2022 stood at $34.7 million, up from $25.6 million in the prior quarter.
  • The five-year high for Short term Debt was $34.7 million in Q4 2022, with the low at $704000.0 in Q4 2020.
  • The 3-year median for Short term Debt is $17.9 million (2022), against an average of $18.3 million.
  • The sharpest annual moves came in 2021 and 2022: Short term Debt surged 1749.01% in 2021, then soared 166.31% in 2022.
  • Trulieve Cannabis' Short term Debt stood at $704000.0 in 2020, then soared by 1749.01% to $13.0 million in 2021, then jumped by 166.31% to $34.7 million in 2022.
  • Business Quant data shows TRLV's Short term Debt at $34.7 million in Q4 2022, $25.6 million in Q3 2022, and $22.1 million in Q2 2022.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2022 34.67 Mn
Sep 30, 2022 25.59 Mn
Jun 30, 2022 22.07 Mn
Mar 31, 2022 13.83 Mn
Dec 31, 2021 13.02 Mn
Dec 31, 2020 704,000.00